20 results
8-K
EX-1.1
VERV
Verve Therapeutics Inc
29 Nov 23
Verve Therapeutics Announces Pricing of Public Offering of Common Stock and Concurrent Private Placement
4:54pm
Adverse Effect. “Hazardous Materials” means any material, chemical, substance, waste, pollutant, contaminant, compound, mixture, or constituent thereof
8-K
EX-1.1
ajqyt n5rbw5
21 Jul 22
Verve Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
4:46pm
S-3
EX-1.2
qdi1bv88k x97n02t
1 Jul 22
Shelf registration
4:36pm
10-K
hxphumm
14 Mar 22
Annual report
7:04am
10-Q
4cnf se2jgvtgs
12 Aug 21
Quarterly report
8:53am
424B4
tc4fu770
17 Jun 21
Prospectus supplement with pricing info
4:50pm
S-1/A
EX-1.1
427x5uypd2uzyqpdhb0
14 Jun 21
IPO registration (amended)
6:15am
S-1/A
8tnz9bx6raypawi
14 Jun 21
IPO registration (amended)
6:15am
S-1
s1sh07moz c5u6
28 May 21
IPO registration
4:04pm
DRS
8my1clf
16 Apr 21
Draft registration statement
12:00am
- Prev
- 1
- Next